secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001816590-25-000141
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Pathways appoints Dr. Jeffrey Jonas to board; Thomas Lönngren to retire Dec 31, 2025
--------------------------------------------------------------------------------

- Dr. Jonas appointed Board effective Oct 29, 2025; Class II director, audit and scientific committees.
- Initial option for 52,000 ordinary shares vesting over 3 yrs; annual retainers $40k board, $10k audit, $6k scientific.
- Thomas Lönngren to retire Dec 31, 2025 after 6+ years; no disagreements.
- Dr. Jonas brings 30+ yrs neuroscience leadership; former CEO of Sage Therapeutics, partner at Cure Ventures.
- Changes align with advancing COMP360 program and potential commercialization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659025000141/0001816590-25-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659025000141/cmps-20251026.htm
  HTML page:      https://secwatch.observer/filing/0001816590-25-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer